Evidence map›Paper›PMID 21892166›Full record

ArticleNature nanotechnology2011

Gold nanoparticles for high-throughput genotyping of long-range haplotypes.

Peng Chen, Dun Pan, Chunhai Fan, Jianhua Chen, Ke Huang, Dongfang Wang, Honglu Zhang, You Li, Guoyin Feng, Peiji Liang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature nanotechnology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 113 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Single-Molecule Nanomechanical Genotyping with DNA Origami-Based Shape IDs.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  5. Article
  6. MoSBioactive materials · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Peng ChenKey Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Bio-X Institutes, Shanghai Jiao Tong University, Shanghai 200030, China.
Dun Pan
Chunhai Fan
Jianhua Chen
Ke Huang
Dongfang Wang
Honglu Zhang
You Li
Guoyin Feng
Peiji Liang
Lin He
Yongyong Shi
Shanghai Jiao Tong University · CNShanghai Institute of Applied Physics · CNChinese Academy of Sciences · CNShanghai Changning Mental Health Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Completion of the Human Genome Project and the HapMap Project has led to increasing demands for mapping complex traits in humans to understand the aetiology of diseases. Identifying variations in the DNA sequence, which affect how we develop disease and respond to pathogens and drugs, is important for this purpose, but it is difficult to identify these variations in large sample sets. Here we show that through a combination of capillary sequencing and polymerase chain reaction assisted by gold nanoparticles, it is possible to identify several DNA variations that are associated with age-related macular degeneration and psoriasis on significant regions of human genomic DNA. Our method is accurate and promising for large-scale and high-throughput genetic analysis of susceptibility towards disease and drug resistance.

Indexed as

Genome, HumanHaplotypesDrug ResistanceGoldHumansMacular DegenerationMetal NanoparticlesPolymerase Chain ReactionPsoriasisSequence Analysis, DNAGold

Identifiers

PMID21892166
OpenAlexW2139024907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.